IBCG25 Annual Retreat
August 22 - August 23
The IBCG25 retreat will bring together global leaders in bladder cancer to advance two high-impact initiatives:
• Biomarkers in Urothelial Cancer: Focused on identifying best practices for biomarker discovery and clinical application—from diagnosis and surveillance to treatment and trial endpoints.
• IBCG Bladder Toxicity Index (IBCG-BTx): A comprehensive framework to measure bladder-specific toxicity across therapies, including radiation, immunotherapy, and surgery.
This year’s meeting will feature collaborative working sessions, invited presentations, and contributions from industry and advocacy partners. More details to follow.